BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35513212)

  • 21. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
    Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
    Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A glutathione-responsive polyphenol - Constructed nanodevice for double roles in apoptosis and ferroptosis.
    Chen H; Yan Z; Wu S; Li F
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111902. PubMed ID: 34107442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
    Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
    Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
    Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
    J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer.
    Wei Y; Zhu Z; Hu H; Guan J; Yang B; Zhao H
    Eur J Pharmacol; 2022 Jun; 924():174970. PubMed ID: 35469839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
    Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
    Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
    Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
    Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy.
    Zheng DW; Lei Q; Zhu JY; Fan JX; Li CX; Li C; Xu Z; Cheng SX; Zhang XZ
    Nano Lett; 2017 Jan; 17(1):284-291. PubMed ID: 28027643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
    Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
    Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
    Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acidity-Biodegradable Iridium-Coordinated Nanosheets for Amplified Ferroptotic Cell Death Through Multiple Regulatory Pathways.
    Huang L; Nie T; Jiang L; Chen Y; Zhou Y; Cai X; Zheng Y; Wang L; Wu J; Ying T
    Adv Healthc Mater; 2023 Apr; 12(10):e2202562. PubMed ID: 36610060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 Promotes Ferroptosis in Macrophages Treated with Fe
    Wu C; Shen Z; Lu Y; Sun F; Shi H
    ACS Appl Mater Interfaces; 2022 Sep; 14(38):42791-42803. PubMed ID: 36112832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic resistance.
    Zhu J; Wang X; Su Y; Shao J; Song X; Wang W; Zhong L; Gan L; Zhao Y; Dong X
    Biomaterials; 2022 Sep; 288():121704. PubMed ID: 35948496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4.
    Chen D; Chu B; Yang X; Liu Z; Jin Y; Kon N; Rabadan R; Jiang X; Stockwell BR; Gu W
    Nat Commun; 2021 Jun; 12(1):3644. PubMed ID: 34131139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic Therapy Initiated Ferrotherapy of Self-Delivery Nanomedicine to Amplify Lipid Peroxidation via GPX4 Inactivation.
    Zhao LP; Chen SY; Zheng RR; Rao XN; Kong RJ; Huang CY; Liu YB; Tang Y; Cheng H; Li SY
    ACS Appl Mater Interfaces; 2022 Dec; 14(48):53501-53510. PubMed ID: 36399048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photothermal-Enhanced Inactivation of Glutathione Peroxidase for Ferroptosis Sensitized by an Autophagy Promotor.
    An P; Gao Z; Sun K; Gu D; Wu H; You C; Li Y; Cheng K; Zhang Y; Wang Z; Sun B
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):42988-42997. PubMed ID: 31650832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
    Shen LD; Qi WH; Bai JJ; Zuo CY; Bai DL; Gao WD; Zong XL; Hao TT; Ma Y; Cao GC
    Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.
    Tarangelo A; Magtanong L; Bieging-Rolett KT; Li Y; Ye J; Attardi LD; Dixon SJ
    Cell Rep; 2018 Jan; 22(3):569-575. PubMed ID: 29346757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese-Based Redox Homeostasis Disruptor for Inducing Intense Ferroptosis/Apoptosis Through xCT Inhibition And Oxidative Stress Injury.
    Dong Q; Wang J; Liu J; Zhang L; Xu Z; Kang Y; Xue P
    Adv Healthc Mater; 2023 Nov; 12(28):e2301453. PubMed ID: 37531240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy.
    Zhou Y; Chen K; Lin WK; Liu J; Kang W; Zhang Y; Yang R; Jin L; Cheng Y; Xu A; Wang W
    Adv Healthc Mater; 2023 Oct; 12(27):e2300994. PubMed ID: 37432874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.